ex-vivo expanded allogeneic γδT cells
/ Beijing GD
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 18, 2024
Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma
(clinicaltrials.gov)
- P1 | N=10 | Not yet recruiting | Sponsor: Xijing Hospital
New P1 trial • Melanoma • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1